CDNA Logo

CareDx, Inc (CDNA) 

NASDAQ
Market Cap
$1.34B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
597 of 966
Rank in Industry
36 of 53

Largest Insider Buys in Sector

CDNA Stock Price History Chart

CDNA Stock Performance

About CareDx, Inc

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Insider Activity of CareDx, Inc

Over the last 12 months, insiders at CareDx, Inc have bought $0 and sold $4.66M worth of CareDx, Inc stock.

On average, over the past 5 years, insiders at CareDx, Inc have bought $240,266 and sold $21.22M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $211,694 was made by Dhingra Ankur (Chief Financial Officer) on 2021‑11‑24.

List of Insider Buy and Sell Transactions, CareDx, Inc

2024-12-04SaleSecretary and General Counsel
1,917
0.0036%
$26.00$49,842-4.05%
2024-11-26Saledirector
5,000
0.0093%
$25.00$125,000-0.64%
2024-11-25SaleSecretary and General Counsel
1,223
0.0023%
$24.00$29,352+3.69%
2024-11-18SaleSecretary and General Counsel
5,534
0.0104%
$21.77$120,477+9.70%
2024-08-21SaleSee Remarks
21,557
0.0399%
$32.58$702,327-18.23%
2024-08-20Saledirector
35,552
0.0686%
$33.04$1.17M-15.47%
2024-08-20SaleSee Remarks
39,466
0.0765%
$33.17$1.31M-15.47%
2024-08-19SaleSee Remarks
34,231
0.0641%
$33.55$1.15M-18.93%
2023-10-02SaleSee Remarks
2,818
0.0052%
$6.91$19,483+48.03%
2023-09-05SaleSee Remarks
2,819
0.0054%
$9.49$26,762+7.49%
2023-08-14SaleSee Remarks
576
0.001%
$8.89$5,123+3.96%
2023-08-02SaleSee Remarks
2,819
0.0053%
$11.35$31,988-13.85%
2023-07-13SaleSee Remarks
5,260
0.01%
$10.33$54,357-3.86%
2023-07-13Saledirector
5,000
0.0095%
$10.34$51,681-3.86%
2023-07-03SaleSee Remarks
2,818
0.0052%
$8.48$23,901+14.49%
2023-06-28SaleSee Remarks
14,268
0.0266%
$8.76$125,016+10.72%
2023-06-28Saledirector
2,432
0.0045%
$8.72$21,216+10.72%
2023-06-02SaleSee Remarks
2,819
0.0053%
$8.13$22,911+14.51%
2023-05-02SaleSee Remarks
2,819
0.0054%
$8.12$22,898+11.00%
2023-04-03SaleSee Remarks
2,818
0.0054%
$8.95$25,225+0.34%

Insider Historical Profitability

58.32%
Maag Peterdirector
330024
0.6153%
$24.96455+57.09%
Johnson Alexander LSee Remarks
284983
0.5313%
$24.9603
Novack Jeffrey AdamSecretary and General Counsel
110237
0.2055%
$24.9603
TPG Group Holdings (SBS) Advisors, Inc.10 percent owner
1075090
2.0045%
$24.9610<0.0001%
BYERS BROOK H
751174
1.4006%
$24.9610<0.0001%
KLEINER PERKINS CAUFIELD & BYERS X A LP10 percent owner
751174
1.4006%
$24.9610<0.0001%
Seeto ReginaldSee Remarks
479164
0.8934%
$24.96034
Gagnon Neil10 percent owner
107940
0.2013%
$24.96481+71.45%
Bell Michael BrianChief Financial Officer
103343
0.1927%
$24.96110+288.89%
Nelles Mitchell JChief Operating Officer
85160
0.1588%
$24.9612<0.0001%
Goldberg Michael
62267
0.1161%
$24.96112<0.0001%
SNYDERMAN RALPHdirector
51015
0.0951%
$24.9605
Yee James PChief Medical Officer
42045
0.0784%
$24.9605
King SashaChief Marketing Officer
40139
0.0748%
$24.96016
Bickerstaff Georgedirector
37736
0.0704%
$24.9605
HAGSTROM WILLIAM Adirector
18575
0.0346%
$24.9606
Whitson ToddChief Commercial Officer
10000
0.0186%
$24.9610<0.0001%
LUDLUM KENChief Financial officer
5000
0.0093%
$24.9610<0.0001%
Dhingra AnkurChief Financial Officer
5000
0.0093%
$24.9610<0.0001%
Colon Grace
4864
0.0091%
$24.9603
TORRES ARTHUR Adirector
2855
0.0053%
$24.9610<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
ARK Investment Management LLC$62.1M11.265.86M-18.5%-$14.09M0.22
BlackRock$57.45M10.425.43M-2.14%-$1.26M<0.01
The Vanguard Group$45.54M8.264.3M+4.38%+$1.91M<0.01
State Street$44.44M8.064.2M+50.07%+$14.83M<0.01
Bellevue Group$41.66M7.553.93M-0.53%-$220,123.740.64
Sumitomo Mitsui Trust Holdings$29.1M5.282.75M-4.4%-$1.34M0.02
Nikko Asset Management Americas Inc$29.08M5.282.75M-4.4%-$1.34M0.22
Gagnon Securities$23.78M4.312.25M+7.13%+$1.58M5.92
D. E. Shaw & Co.$21.41M3.882.02M-8.14%-$1.9M0.02
Dimensional Fund Advisors$15.31M2.781.45M+39.08%+$4.3M<0.01
Renaissance Technologies$15.09M2.741.42M+4.59%+$661,896.320.02
Bamco$13.02M2.361.23MNew+$13.02M0.04
Geode Capital Management$12.66M2.291.2M+3.12%+$382,350.80<0.01
Jacobs Levy Equity Management$12.19M2.211.15M+8.72%+$978,124.130.04
First Eagle Investment Management$10.64M1.931.01M-11.15%-$1.34M0.02
Morgan Stanley$9.88M1.79932,617-40.91%-$6.84M<0.01
Acadian Asset Management$9.21M1.67869,518+4.68%+$411,725.720.03
Gagnon Advisors LLC$6.46M1.17610,336+10%+$587,586.136.22
Bank of Montreal$6.49M1.12584,056-0.25%-$16,042.84<0.01
Charles Schwab$6.02M1.09568,500+28.05%+$1.32M<0.01
ROYCE & ASSOCIATES INC$5.7M1.03538,298+56.62%+$2.06M0.05
Goldman Sachs$5.62M1.02530,266+13.03%+$647,313.76<0.01
AQR Capital$4.76M0.86449,141+123.87%+$2.63M0.01
Northern Trust$4.65M0.84439,032-1.75%-$82,612.59<0.01
Citigroup$4.15M0.75391,821+373.57%+$3.27M<0.01
Rafferty Asset Management Llc$3.86M0.7364,799+91.6%+$1.85M0.01
Assenagon Asset Management S.A.$3.78M0.69356,573-38.13%-$2.33M0.01
Cadian Capital Management LP$3.21M0.58303,106New+$3.21M0.11
Cubist Systematic Strategies$2.9M0.53273,849+26.08%+$599,881.160.03
Marshall Wace$2.82M0.51266,713+489.26%+$2.35M<0.01
Connor Clark & Lunn Investment Management Ltd$2.77M0.5261,745+55.51%+$989,423.860.01
Los Angeles Capital Management LLC$2.74M0.5259,007+9.23%+$231,836.270.01
Mirae Asset Global Investments Co Ltd$2.03M0.44228,198+87.76%+$950,873.82<0.01
UBS$2.4M0.43226,166+61.12%+$908,558.48<0.01
Arrowstreet Capital, Limited Partnership$2.3M0.42216,891-37.3%-$1.37M<0.01
Engineers Gate Manager Lp$2.01M0.36189,594+14.26%+$250,569.930.05
Wellington Management Company$2M0.36188,710+126.98%+$1.12M<0.0001
Ameriprise Financial$1.99M0.36187,998-0.89%-$17,770.02<0.01
Two Sigma Advisers LP$1.99M0.36187,700-18%-$436,308.00<0.01
Alger$1.97M0.36186,048New+$1.97M0.01
State of Wisconsin Investment Board$1.96M0.36185,513+154.08%+$1.19M0.01
BNY Mellon$1.92M0.35181,590-6.62%-$136,293.29<0.0001
Millennium Management LLC$1.91M0.35180,601-30.02%-$820,312.17<0.01
Bullseye Asset Management LLC$1.85M0.34174,8200%+$00.87
Bank of America$1.78M0.32168,473-28.1%-$697,150.26<0.0001
Deutsche Bank$1.56M0.28146,916+0.46%+$7,148.25<0.01
Nuveen$1.45M0.26137,2600%+$0<0.0001
ARS Investment Partners, LLC$1.42M0.26134,110-11.48%-$184,266.010.14
Prudential Financial$1.36M0.25128,044-45.08%-$1.11M<0.01
Russell Investments Group Ltd$1.29M0.24122,227+34.97%+$335,353.29<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.